NRIX- Nurix Therapeutics, Inc.

Name: Nurix Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nurix Therapeutics, Inc. (NRIX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Hansen Gwenn	125.2K	$3.16M	-3,847
Other	Ring Christine	122.8K	$3.10M	-20,436
Dir	Dansey Roger D	50.0K	$1.26M	-
CFO	Van Houte Hans	40.2K	$1.01M	-7,606
Dir	Gregory Julia P	10.8K	$271.1K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 4, 2026	Van Houte Hans60	Chief Financial Officer	Sell	4,761	$24.36	$115,989.47	-5.4%	-	-
Aug 3, 2026	Ring Christine77	Chief Legal Officer	Sale+OE	16,589	$23.05	$382,358.20	-64.6%	-	-
Jul 30, 2026	Hansen Gwenn72	Chief Scientific Officer	Sale+OE	3,847	$23.38	$89,953.63	-3.1%	-	-
Jul 30, 2026	Ring Christine77	Chief Legal Officer	Sale+OE	3,847	$23.38	$89,953.63	-16.2%	-	-
Jul 30, 2026	Van Houte Hans60	Chief Financial Officer	Sale+OE	2,845	$23.38	$66,524.07	-6.0%	-	-
Jul 2, 2026	Ring Christine77	Chief Legal Officer	Sale+OE	11,008	$23.56	$259,366.09	-44.8%	-	-
Jun 25, 2026	Ring Christine77	Chief Legal Officer	Sale+OE	28,935	$20.06	$580,505.54	-68.1%	-	-
Jun 25, 2026	Hansen Gwenn72	Chief Scientific Officer	Sell	5,394	$20.00	$107,880.00	-4.5%	-	-
Jun 2, 2026	Ring Christine77	Chief Legal Officer	Sale+OE	8,148	$16.60	$135,252.73	-37.5%	-	-
May 1, 2026	Ring Christine77	Chief Legal Officer	Sell	5,394	$16.76	$90,406.68	-16.9%	+40.3%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC